Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The pharmaceutical industry.

L Lewis, S Siegelman

    The State of Health Care in America
    |December 9, 1992
    PubMed
    Summary
    This summary is machine-generated.

    Pharmaceutical research has shifted from infectious diseases to chronic illnesses. The focus is now on developing new strategies for the prevention, treatment, and cure of conditions like cardiovascular disease and cancer.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Physician associates in interventional radiology: a new paradigm?

    Clinical radiology·2023
    Same author

    Parathyroid hormone changes in infants investigated for inflicted injury; an observational retrospective single centre cohort study.

    Child abuse & neglect·2022
    Same author

    The Reference Site Collaborative Network of the European Innovation Partnership on Active and Healthy Ageing.

    Translational medicine @ UniSa·2019
    Same author

    Underestimation of spirometry if recommended testing guidance is not followed.

    Occupational medicine (Oxford, England)·2018
    Same author

    Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project).

    Allergy·2017
    Same author

    Metal nanoinks as chemically stable surface enhanced scattering (SERS) probes for the analysis of blue BIC ballpoint pens.

    Physical chemistry chemical physics : PCCP·2017
    Same journal

    Can sin taxes and lawsuits make us healthier?

    The state of health care in America·2002
    Same journal

    The health policy home fires are still burning.

    The state of health care in America·2002
    Same journal

    Still no answer for the uninsured.

    The state of health care in America·2002
    Same journal

    How long can employers hang on?

    The state of health care in America·2002
    Same journal

    Population-based medicine: a winding road to nowhere?

    The state of health care in America·2002
    Same journal

    Healthier communities on the horizon.

    The state of health care in America·2002
    See all related articles

    Area of Science:

    • Medical Research
    • Drug Discovery
    • Public Health

    Background:

    • Historically, pharmaceutical research prioritized infectious disease eradication.
    • Many infectious diseases are now largely controlled or eliminated.
    • A significant shift in focus towards chronic, non-communicable diseases is evident.

    Purpose of the Study:

    • To highlight the evolving landscape of pharmaceutical research.
    • To underscore the increasing importance of addressing chronic illnesses.
    • To examine the transition from infectious disease research to chronic disease management.

    Main Methods:

    • Literature review of historical and current pharmaceutical research trends.
    • Analysis of disease prevalence and research funding shifts.

    Related Experiment Videos

  • Comparative study of research priorities over time.
  • Main Results:

    • Pharmaceutical research has largely succeeded in combating infectious diseases.
    • Chronic diseases like cardiovascular disease and cancer represent a growing burden.
    • There is a discernible increase in research efforts targeting the prevention and treatment of chronic conditions.

    Conclusions:

    • The paradigm of pharmaceutical research has fundamentally shifted.
    • Future pharmaceutical innovation must prioritize chronic disease management.
    • Continued investment in research for cardiovascular disease, cancer, and other chronic illnesses is crucial.